|
Volumn 57, Issue 8, 2008, Pages 1034-1035
|
Coeliac disease and the risk of infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CATHELICIDIN;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
IMMUNOGLOBULIN M;
INFLUENZA VACCINE;
PNEUMOCOCCUS VACCINE;
PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;
BACTERICIDAL ACTIVITY;
CELIAC DISEASE;
COMMON VARIABLE IMMUNODEFICIENCY;
DIAGNOSTIC VALUE;
DIFFERENTIAL DIAGNOSIS;
ENDOTOXEMIA;
ENTEROPATHY;
FOLLOW UP;
GLUTEN FREE DIET;
HAEMOPHILUS INFLUENZAE TYPE B;
HIP FRACTURE;
HUMAN;
HUMAN TISSUE;
HYPOSPLENISM;
IMMUNIZATION;
INFECTION RISK;
INTESTINE FLORA;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MEMORY CELL;
NATURAL KILLER T CELL;
NOTE;
PREVALENCE;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RISK ASSESSMENT;
RISK FACTOR;
RISK REDUCTION;
SEPSIS;
SPLEEN DISEASE;
SPLENECTOMY;
STAPHYLOCOCCUS INFECTION;
STATISTICAL ANALYSIS;
STREPTOCOCCUS INFECTION;
SWEDEN;
TUBERCULOSIS;
VITAMIN D DEFICIENCY;
CELIAC DISEASE;
HUMANS;
OPPORTUNISTIC INFECTIONS;
RISK ASSESSMENT;
SEPSIS;
|
EID: 48249104250
PISSN: 00175749
EISSN: None
Source Type: Journal
DOI: 10.1136/gut.2008.151571 Document Type: Note |
Times cited : (19)
|
References (12)
|